Skip to main content
Premium Trial:

Request an Annual Quote

BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies: Sep 30, 2004

 

BCW Index Takes its First Dip, Falls 8 Percent

After three weeks of gains, the BioCommerce Week Index of Diversified Molecular Biology Tool Companies finished down this week, finishing at $31.25 Tuesday, down 3 percent from last week’s $32.19 close.

The fall is in step with broader market measures. The Dow, the S&P 500, and Nasdaq — as well as the Nasdaq biotech — all finished down, between 1 and 2 percent lower than last week.

Of the 15 companies in the BCW Index, 12 saw their share prices fall during the week. Agilent led this group, falling to $21.29 from $23.32, an 8 percent drop, while shares of Molecular Devices, Waters, PerkinElmer, and Invitrogen fell more than 5 percent during a week when many of the BCW Index company executives were in New York to present at the annual UBS Global Life Sciences Conference.

Beckman Coulter and Applied Biosystems recorded fractions-of-a-percentage gains while Harvard Bio ended even at $4.45.

Agilent’sdrop comes after making gains of 14 percent over the previous weeks since the Index was first published on Sept. 8.

PerkinElmer, even with a 5.38-percent dip this week, still is above its index-opening price of $18.71, while Applied Bio dips below its index opening price of $18.81.

After gaining nearly 20 percent from the start of the index, Invitrogen stands at $55.38, after starting at $48.87.

The index is a weekly compilation of stock prices of a select group of public molecular biology tools companies with multiple platform technologies, and business units with executives dedicated to integrated biology efforts, or with investments in this emerging field.

— Mo Krochmal ([email protected])

File Attachments
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.